Australia's ResApp Health eyes best day in nearly 2 years on positive COVID screening test results

Raptor Metals

22/03/2022 24:06

** Shares of ResApp Health  RAP.AX  rise as much as 69.4% to
A$0.105, set for their best day since March 24, 2020, if gains
hold 
    ** The digital healthcare services provider announces https://www.asx.com.au/asxpdf/20220322/pdf/4577d1y053bqqt.pdf
 positive results for a cough audio-based COVID-19 screening
test that only requires a smartphone
    ** Says co's screening test, which uses machine learning to
analyse the sound of a patient's cough, was found to correctly
detect COVID-19 in 92% of people with the infection
    ** Co will initially target use in settings where COVID-19
testing is required such as among employees, healthcare workers,
students as well as travel, sports, entertainment and aged care
    ** Stock hits highest level since Oct 29, 2020
    ** More than 10 mln shares change hands, vs the 30-day
average of about 675,000 shares 
    ** As of last close, ResApp down ~4.6% this year


 (Reporting by Upasana Singh in Bengaluru)
 ((Upasana.Singh@thomsonreuters.com))